Related Experiment Videos
Prognostic factors in breast cancer
1Northwestern University Medical School, Division of Medical Oncology, Evanston Hospital, Illinois.
Hematology/Oncology Clinics of North America
|December 1, 1989
Summary
Identifying high-risk breast cancer patients is crucial for effective treatment. Combining multiple tumor characteristics helps determine which patients need adjuvant therapy, especially for node-negative cases.
Area of Science:
- Oncology
- Pathology
- Genetics
Background:
- Accurate prognostication is vital for managing primary breast cancer.
- Identifying high-risk patients, particularly node-negative, is essential for appropriate adjuvant therapy selection.
- Established and emerging prognostic factors guide treatment decisions.
Purpose of the Study:
- To review established and potential prognostic factors in primary breast cancer.
- To guide the selection of high-risk patients for adjuvant treatment.
- To emphasize the need for an individualized approach in breast cancer management.
Main Methods:
- Review of established and emerging prognostic indicators for breast cancer.
- Analysis of tumor characteristics including size, receptor status, grade, ploidy, and HER-2 amplification.
- Discussion of the clinical utility and limitations of various prognostic markers.
Main Results:
- Tumor size and ER status are established prognostic factors.
- Histologic grade, DNA ploidy, and S-phase fraction require further validation due to interobserver variability and standardization issues.
- Progesterone-receptor status, axillary node involvement, and HER-2 status are also important predictors.
Conclusions:
- No single factor fully predicts breast cancer relapse; a multi-parameter approach is necessary.
- Adjuvant therapy decisions should be based on a comprehensive assessment of multiple high-risk characteristics.
- Further large-scale, prospective studies are needed to refine prognostic models and guide individualized breast cancer treatment.